ARCHIVES

In Brief: FDA Approves G-CSF For Marketing; Walkmann Wins Belgian Health Prize; Green To Head NWTS

This article is from The Cancer Letter archive.

Vol. 17 No. 09 | March 1, 1991

Download PDF Visit The Full Archive

Related Articles

Studies Question PSA Screening: PLCO Trial Finds No Survival Advantage, European Trial Finds Benefit At High Cost

March 20, 2009

Navelbine+Herceptin: 78% Response In Breast Cancer

November 29, 2002

NCAB Asks For Cost Reimbursement n Patients In Clinical Trials Until More Data Available

October 5, 1984

Joseph Cullen, Cancer Prevention Leader, Dead At 54

November 30, 1990

Research Regulation: NRC fines NIH for Not Securing Radioactive Materials

September 13, 1996

Advances In Cancer Control Meeting Is Set For March 22

February 3, 1989